BDX•benzinga•
BD Announces First Patient Treated In Investigational Device Exemption Trial Intended To Achieve FDA Premarket Approval For Use Of GalaFLEX LITE Scaffold In Breast Implant Revision Surgery
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 20, 2025 by benzinga